Relay Therapeutics, Inc. - RLAY

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Apr 13, 2026 SCHEDULE 13G Perceptive Advisors LLC 9.99% 438,471 View
Apr 13, 2026 SCHEDULE 13G Joseph Edelman 9.99% 438,471 View
Apr 13, 2026 SCHEDULE 13G Perceptive Life Sciences Master Fund, Ltd. 9.99% 438,471 View
Mar 27, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Mar 19, 2026 SCHEDULE 13G Perceptive Advisors LLC 5.3% 9,404,725 View
Mar 19, 2026 SCHEDULE 13G Joseph Edelman 5.3% 9,404,725 View
Mar 19, 2026 SCHEDULE 13G Perceptive Life Sciences Master Fund, Ltd. 5.3% 9,404,725 View
Feb 17, 2026 SCHEDULE 13G/A CASDIN CAPITAL, LLC 7.5% 13,003,574 View
Feb 17, 2026 SCHEDULE 13G/A CASDIN PARTNERS MASTER FUND, L.P. 7.3% 12,585,000 View
Feb 17, 2026 SCHEDULE 13G/A CASDIN PARTNERS GP, LLC 7.5% 13,003,574 View
Feb 17, 2026 SCHEDULE 13G/A ELI CASDIN 7.5% 13,003,574 View
Feb 17, 2026 SCHEDULE 13G/A CASDIN CAPITAL, LLC 7.5% 13,003,574 View
Feb 17, 2026 SCHEDULE 13G/A CASDIN PARTNERS MASTER FUND, L.P. 7.3% 12,585,000 View
Feb 17, 2026 SCHEDULE 13G/A CASDIN PARTNERS GP, LLC 7.5% 13,003,574 View
Feb 17, 2026 SCHEDULE 13G/A ELI CASDIN 7.5% 13,003,574 View
Nov 14, 2025 SCHEDULE 13G/A Commodore Capital LP 9.9% 17,000,000 View
Nov 14, 2025 SCHEDULE 13G/A Commodore Capital Master LP 9.9% 17,000,000 View
Nov 14, 2025 SCHEDULE 13G/A Robert Egen Atkinson 9.9% 17,000,000 View
Nov 14, 2025 SCHEDULE 13G/A Michael Kramarz 9.9% 17,000,000 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.